VIUSID creates perfect synergy with COVID Vaccines!
King's Cross Pharmaceuticals, Inc. (KCPI), a subsidiary of King's Cross Veterinary and Nutrition, Inc. was established on February 2019. KCPI's main purpose is to distribute safe and effective supplements and dermatological products for various types of illness and diseases. Our products are harmless and based on the latest discoveries of the beneficial effects that ANTIOXIDANTS have on FREE RADICALS in our organism as well as on the stimulation of the body's immune system.
King's Cross Pharmaceuticals is the exclusive distributor in the Philippines of Catalysis, S.L. a private and independent company from Spain that dedicates its efforts to research and the development of products in the pharmaceutical, cosmetic, and dietary fields. Catalysis team of scientists works at the search of new remedies to relieve suffering caused by widespread diseases such as psoriasis, diabetes, asthma, osteoporosis, arthritis, genital and oral herpes, immunodepression (AIDS), cancer, tuberculosis, hepatitis and much more.
Contact details :
Catalysis S.L. started out as a private, independent company concentrating its efforts on research and on the development of products in the cosmetic and dietetic sectors.
The company philosophy is to manufacture highly effective products which do not produce side effects. These objectives have been achieved, thanks to the development of molecular activation, a new global pioneer technology. Molecular Activation is the process of exposing molecules to a specific electric field with specific physico-chemical life processes, thus increasing the biological properties of these molecules. Not all molecules can be activated and this process does not alter their chemical structure. Catalysis products are harmless; they are based on the latest discoveries concerning the beneficial effects which ANTI-OXIDANTS and ANTI-FREE RADICALS have on our organism. Manufactured by laboratories equipped with the most advanced technologies, Catalysis products are subject to the strictest quality controls demanded by European standards.
Based on this technology, Catalysis S.L. have developed a range of products focused on the prevention or treatment of different illnesses which fall within infectology, dermatology, endocrinology, cancer, traumatology, urology and respiratory tract and neuronal complaints.